ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report included.

November 5, 2004

Sentinel Node Disection No Worse Than Axillary

February 25, 2011

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

Cooperative Group Chairman Blast Cut In’81 Budget

February 15, 1980

New Structure Of Divisions Outlined

September 15, 1995

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014